Some people are called analysts because they look at how companies are doing and make predictions about how their stocks will perform. They sometimes have different opinions about a company's stock, and some are better at making accurate predictions than others. In this article, they talk about three health care companies that pay their shareholders a lot of money every year, which is called a dividend. The article lists some of the predictions these analysts have made about the stocks of Pfizer, GSK, and CVS, which are all health care companies. The article also talks about some recent news about these companies. Read from source...

- The article is not focused on the topic of psychedelics, but rather on dividend-yielding stocks in the health care sector.
- The article title is misleading and does not reflect the content of the story.
- The article body is full of irrelevant and unrelated information, such as analyst ratings, price targets, earnings, news, etc.
- The article does not provide any data, evidence, or arguments to support the claims of being "most accurate analysts".
- The article does not explain how the analysts' ratings affect the psychedelics industry or the stocks' performance.
- The article does not mention any psychedelics-related stocks or companies, or any trends or developments in the psychedelics market.
- The article is mainly a promotional piece for Benzinga's services and tools, which is inappropriate for a news article.